Kyverna Therapeutics, Inc. (KYTX) Tops Q1 EPS by 38c

Kyverna Therapeutics, Inc. (NASDAQ: KYTX) reported Q1 EPS of ($0.66), $0.38 better than the analyst estimate of ($1.04).

For earnings history and earnings-related data on Kyverna Therapeutics, Inc. (KYTX) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• Saudi Arabia shuts East-West Pipeline after attacks